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Introduction
Transplantation of the whole or part of the liver is
currently the only well-established treatment of a
spectrum of life-threatening liver diseases, including
acute liver failure, hepatic cirrhosis, and several
inherited metabolic diseases that result from an
absence or deficiency of hepatocyte-derived gene
products [1]. Due to the shortage of donor organs,
several bioartificial liver devices are currently under
investigation in several centers [2]. Hopefully they
will prove to be effective in supporting patients with
liver failure that are on the high urgency waiting-list
for liver transplantation [3]. In the inherited meta-
bolic diseases of the liver, transplantation of hepato-
cytes obtained from an allogeneic donor liver could
provide specific liver functions. In addition, trans-
plantation of isolated, autologous hepatocytes may
provide a means for hepatocyte-directed ex vivo gene
therapy [1,4].
Much work has been done concerning hepatocyte
transplantation in rodents, with intraportal and
intrasplenic routes producing the best results with
respect to engraftment, function, and cell survival
[5]. The optimal site and methods for implantation
of isolated hepatocytes in large animals still remains
to be determined, despite its importance for clinical
application of hepatocyte transplantation. The aim of
this study was to examine intra-abdominal, ectopic
implantation sites for hepatocyte transplantation in a
large animal model, i.e. in the pig.
Materials and methods
Animals
Nine adult white female pigs were used, weighing
between 40 and 44 kg. All procedures were approved
by the institutional guidelines of the Animal Ethical
Committee of the University of Amsterdam.
After fasting overnight, induction of anesthesia was
achieved with intramuscular administration of keta-
mine (10 mg/kg; Nimatec†, Eurovet, Bladel, The
Netherlands), azaperon (2 mg/kg; Stresnil†, Janssen
Pharmaceutica, Tilburg, The Netherlands), and atro-
pine (0.02 mg/kg). After inhalation of a mixture
of O2:NO2 (2:3) and isoflurane (0.41%, Abbott
Laboratories Ltd, Queensborough, UK), pigs were
endotracheally intubated and ventilated with a mix-
ture of O2 and air. Anesthesia was maintained by
intravenous administration (0.5 ml/kg/h) of a mixture
of sufentanilcitrate (20 mg/l, Janssen-Cilag, Tilburg,
The Netherlands) and ketamine (20 g/l). Muscle
relaxation was obtained by intravenous administration
(2 ml/h) of pancuronium bromide (2 mg/ml, Organon
Teknika BV, Boxtel, The Netherlands).
Partial liver resection and hepatocyte isolation
A laparotomy was performed using a small upper
abdominal midline incision. The portal vein and
hepatic artery were dissected free in the hepatoduo-
denal ligament. The left lateral portal vein was
selectively cannulated and flushed with saline. The
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discolored liver segments were resected using electro-
cautery and vessel ligation and were immediately
processed for hepatocyte isolation.
Hepatocytes were isolated according to a modified
method as described by Seglen [6], by perfusing the
portal vein of the excised liver segments with oxyge-
nated Ca2-free solution (378C) and a digestion
buffer that contained 0.00625% (w/v) Liberase RH
(Roche, Almere, The Netherlands). The capsule of
the liver was opened and the digested parenchyma was
collected on ice after filtration through surgical gauze.
The cell suspension was diluted with ice-cold Hanks’
buffer solution and washed three times by centrifuga-
tion at 48C and 50 g for 3 min followed by resuspen-
sion in Hanks’ buffer solution to obtain the required
concentration. Viability of hepatocytes was assessed
by the trypan blue exclusion test. The whole proce-
dure until implantation took 2.53 h, during which
time the animals were kept under anesthesia.
Grafting of hepatocytes
The hepatocyte suspension containing 40106 cells/
ml was slowly injected with a 25-gauge needle into the
spleen (1.5 ml deposits, while clamping the vascular
pedicle) and into the pancreas, mesentery, stomach,
and proximal and distal small bowel wall (0.25
0.5 ml deposits). In the control animal, the same
implantation sites were injected with saline. All
implantation sites were marked with a nonabsorbable
suture. Postoperative pain was treated with Temgesic
0.0050.01 mg/kg as clinically indicated.
Graft assessment
At 13 months post-implantation, the animals were
anesthetized once more, and HIDA-Tc99 (200 MBq
activity, in 20 ml) was administered intravenously
(i.v.), after which the animals were sacrificed. Total
body scanning was performed in the first five animals.
In all animals the spleen, the pancreas, and the
injected regions of mesentery, stomach, and small
bowel wall were subsequently excised and placed
under the gamma camera for organ scanning. Finally,
the implantation sites were excised, immersed in 4%
formaldehyde, and placed in a gamma counter for
direct tissue counting, after which histopathologic
examination of sections stained with hematoxylin
and eosin (H&E) was carried out using bright-field
microscopy.
Results
Cell isolation of the left-lateral liver segments yielded
6.5109 to 7.7109 hepatocytes. Viability of hepa-
tocytes as based on the trypan blue exclusion
test ranged from 75% to 97%. During total body
scanning, radioactivity was only detected in the
region of the remnant liver. Organ scanning showed
radioactivity at the implantation sites in the mesentery
and proximal jejunum, in two transplanted animals
after 1 and 3 months, respectively (n9). Radio-
activity at these sites assessed by direct tissue counting
was 10.4% and 42.0%, respectively, relative to the
radioactivity measured in samples of the remnant liver
of the same animals. Radioactivity at the remaining
injection sites in these animals, as well as at all
injection sites in the other animals, showed only
minimal or no increased radioactivity when compared
to sites in the control animal (all injected with saline).
Histologic examination showed clusters of morpho-
logically normal hepatocytes at the implantation sites
in the mesentery, bowel wall, and stomach in all
transplanted animals. Within these clusters of hepa-
tocytes, sinusoid-like structures and ductular differ-
entiation were observed. The hepatocytes injected
into the subserosa of the bowel wall were localized in
the submucosal layer directly adjacent to the mucosa
in all transplanted animals (Figures 1 and 2). In the
pancreas, hepatocytes were only occasionally detected
in two transplanted animals. In the spleen, no
hepatocytes could be detected in any of the animals.
Overall, histologic findings did not seem to have been
influenced by observation time.
Discussion
This study assessed the feasibility of hepatocyte
transplantation in stomach and bowel wall in pigs.
Hepatocyte transplantation offers considerable advan-
tages to whole (or auxiliary) liver transplantation,
especially when it comes to substitution of one
enzyme function such as in several inherited meta-
bolic liver diseases. The two important issues in this
field are the optimal route for transplantation of
hepatocytes and the limits to the number of hepato-
cytes that can be transplanted at one time. Obviously,
only the possibility of transplanting large quantities
of liver cells, which would also need to function
Figure 1. Microphotograph of an H&E-stained paraffin section of
the implantation site of hepatocytes in small bowel wall, showing
two clusters of hepatocytes (arrows).
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immediately, would enable the use of hepatocyte
transplantation in the setting of acute liver failure.
The great majority of studies on hepatocyte trans-
plantation and its morphologic, cytokinetic, and
metabolic aspects have been performed in small
animals, i.e. rats and mice. Most research groups
have chosen the spleen as the preferred acceptor site
in rats or the recipient liver after intraportal injection
of the hepatocytes. Clinical use of techniques of
hepatocyte transplantation, however, would require
demonstration of function in a large animal before
application in humans. Only a few studies have been
performed examining hepatocyte transplantation in
large animals, such as in pigs, and these studies
mainly focused on intraportal and intrasplenic trans-
plantation [79].
The choice of small bowel wall and stomach as
implantation sites is based on the embryonic origin of
the liver in the foregut and the hepatotrophic stimulus
to which implanted hepatocytes are exposed when
implanted in the drainage area of the portal vein. An
additional therapeutic option in case of successful
hepatocyte transplantation into the stomach wall
would be the possibility of endoscopic access to
deliver therapeutic hepatocyte injections.
In the present report, autologous hepatocytes were
transplanted in pigs, using the spleen, the pancreas,
mesentery, stomach, and small bowel wall as implan-
tation sites. Although large numbers of hepatocytes
were injected into the parenchyma of the spleen, while
the afferent and efferent vessels were clamped, no
hepatocytes were found at 13 months after implan-
tation. Presumably, most hepatocytes were lost due to
embolization of the cells through the efferent vessels
of the spleen. In contrast, the mesentery, stomach,
and small bowel wall showed evident take of hepato-
cytes, as detected by direct scintigraphy and micro-
scopic examination. The normal morphology and the
fact that in some animals these hepatocytes showed
uptake of HIDA-Tc99, suggest that these hepatocytes
are functionally intact. A remarkable finding was the
migration of hepatocytes into the submucosa directly
adjacent to the mucosal layer of the bowel wall and
around nerves.
The use of total body scanning after i.v. injection
of HIDA-Tc99 is theoretically attractive to detect
functioning hepatocytes after implantation in a
non-invasive manner, also allowing for repeated
assessments in the same animal. However, the con-
centration of the radioactive substance at the implan-
tation sites was far too low to be detected by external
total body scintigraphy. Even with scanning of the
excised organs or direct tissue counting, the yield of
scintigraphic assessment was limited. Hence, micro-
scopic evaluation proved most reliable for localization
of surviving hepatocytes at the implantation sites.
In conclusion, these data demonstrate the proof of
principle that hepatocytes can implant in the organ
wall of gastrointestinal organs and that in pigs, the
mesentery and small bowel wall provide more favor-
able sites for transplantation of hepatocytes than the
pancreas or spleen. Whole body or direct scintigraphic
methods for detection of surviving hepatocytes
showed no benefits compared to microscopic assess-
ment.
Acknowledgements
The authors gratefully acknowledge J. Dries, G.
Huyzer, M. Klein, and H. De Wit for their help in
performing the experiments, and R. Hartman for
performing the hepatocyte isolations.
References
[1] Ohashi K, Park F, Kay MA. Hepatocyte transplantation:
clinical and experimental application. J Mol Med 2001;/79:/
61730.
[2] Van de Kerkhove MP, Hoekstra R, Chamuleau RAFM, Van
Gulik TM. Clinical application of bioartificial liver support
systems. Ann Surg 2004;/240:/21630.
[3] Van de Kerkhove MP, Poyck PPC, Deurholt T, Hoekstra R,
Chamuleau RAFM, Van Gulik TM. Liver support therapy: an
overview of the AMC-bioartificial liver research. Dig Surg
2005;/22:/25464.
[4] Raper SE, Wilson JM. Cell transplantation in liver-directed
gene therapy. Cell Transplant 1993;/2:/381400.
[5] Gupta S, Gorla GR, Irani AN. Hepatocyte transplantation:
emerging insights into mechanisms of liver repopulation and
their relevance to potential therapies. J Hepatol 1999;/30:/162
70.
[6] Seglen PO. Preparation of isolated rat liver cells. Methods Cell
Biol 1976;/13:/2983.
[7] Fujioka H, Hunt PJ, Rozga J, Wu GD, Cramer DV, Demetriou
AA, et al. Carboxyfluorescein (CFSE) labelling of hepatocytes
for short-term localization following intraportal transplantation.
Cell Transplant 1994;/3:/397408.
[8] Muraca M, Neri D, Parenti A. Intraportal hepatocyte trans-
plantation in the pig: hemodynamic and histopathological
study. Transplantation 2002;/73:/8906.
[9] Rosenthal RJ, Chen SC, Hewitt W. Techniques for intrasplenic
hepatocyte transplantation in the large animal model. Surg
Endosc 1996;/10:/10759.
Figure 2. Microphotograph of an H&E-stained paraffin section of
the implantation site of hepatocytes in the mesentery, showing
several hepatocyte clusters (arrows).
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